Patent Assignment
Reel/Frame 020234/0460
Assignment of Assignor's Interest
Recorded: 2007-12-13
Pages: 8
Assignor
CORDIS CORPORATION
Executed: 2007-12-12
Assignee
WYETH
5 GIRALDA FARMS, MADISON, NEW JERSEY, 07940
Covered Properties
(63)
Drug Combination Useful for Prevention of Restenosis
Patent:
8,029,561 →
Application:
09/575,480 →
Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease
Drug/drug delivery systems for the prevention and treatment of vascular disease
Application:
09/850,233 →
Publication:
US 2002/0007213
Drug/drug delivery systems for the prevention and treatment of vascular disease
Application:
09/850,293 →
Publication:
US 2002/0007214
Drug/drug delivery systems for the prevention and treatment of vascular disease
Application:
09/850,365 →
Publication:
US 2002/0007215
Drug combinations and delivery devices for the prevention and treatment of vascular disease
Application:
09/850,482 →
Publication:
US 2001/0029351
Antiproliferative drug and delivery device
Application:
09/850,507 →
Publication:
US 2002/0005206
Local Drug Delivery Devices and Methods for Maintaining the Drug Coatings Thereon
Coatings for Medical Devices
Medical devices, drug coatings and methods for maintaining the drug coatings thereon
Application:
09/962,496 →
Publication:
US 2002/0111590
Coated Medical Devices
Coated Medical Devices for the Treatment of Vulnerable Plaque
Coated medical devices
Application:
10/136,569 →
Publication:
US 2003/0065377
Stent Delivery System Having a Fixed Guidewire
Method and apparatus for treating vulnerable coronary plaques using drug-eluting stents
Application:
10/185,021 →
Publication:
US 2004/0002755
Coated vascular devices
Application:
10/208,581 →
Publication:
US 2003/0204168
Anastomosis devices and methods for treating anastomotic sites
Application:
10/274,770 →
Publication:
US 2003/0065345
Drug Releasing Anastomosis Devices and Methods for Treating Anastomotic Sites
Method for Coating Medical Devices
Coated medical devices
Application:
10/371,925 →
Publication:
US 2004/0167572
Coated Medical Devices for the Prevention and Treatment of Vascular Disease
Balloon Catheter Stent Delivery System with Ridges
Local Vascular Delivery of Trichostatin a Alone or in Combination with Sirolimus to Prevent Restenosis Following Vascular Injury
Local Vascular Delivery of Mycophenolic Acid in Combination with Rapamycin to Prevent Restenosis Following Vascular Injury
Implantable Structures for Local Vascular Delivery of Cladribine in Combination with Rapamycin for Restenosis
Local Vascular Delivery of Topotecan in Combination with Rapamycin to Prevent Restenosis Following Vascular Injury
Local Vascular Delivery of Etoposide in Combination with Rapamycin to Prevent Restenosis Following Vascular Injury
Coated Medical Device for Local Vascular Delivery of Panzem in Combination with Rapamycin to Prevent Restenosis Following Vascular Injury
Solution Formulations of Sirolimus and Its Analogs for Cad Treatment
Drug delivery device
Application:
10/813,976 →
Publication:
US 2005/0220836
Use of Antioxidants to Prevent Oxidation and Reduce Drug Degradation in Drug Eluting Medical Devices
Local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque
Application:
10/826,058 →
Publication:
US 2005/0232965
Drug/drug delivery systems for the prevention and treatment of vascular disease
Application:
10/829,044 →
Publication:
US 2005/0002986
Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease
Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease
Antiproliferative drug and delivery device
Application:
10/852,517 →
Publication:
US 2004/0243097
Heparin Barrier Coating for Controlled Drug Release
Coating for controlled release of a therapeutic agent
Application:
10/883,328 →
Publication:
US 2005/0033417
Method for filtering blood in a vessel with helical elements
Application:
10/896,481 →
Publication:
US 2006/0020285
Method for Applying Drug Coating to a Medical Device in Surgeon Room
Kit for applying drug coating to a medical device in surgeon room
Application:
10/916,181 →
Publication:
US 2005/0038504
Biodegradable Intralumenal Device
Method and apparatus for treating vulnerable coronary plaques using drug-eluting stents
Application:
10/969,260 →
Publication:
US 2005/0113907
Device for the delivery of a cardioprotective agent to ischemic reperfused myocardium
Application:
11/013,081 →
Publication:
US 2006/0129225
Intraluminal Medical Devices in Combination with Therapeutic Agents
Coated aneurysmal repair device
Application:
11/149,466 →
Publication:
US 2005/0249776
System for treating aneurysmal disease
Application:
11/193,177 →
Publication:
US 2007/0026042
Solvent Free Amorphous Rapamycin
Antithrombotic coating for drug eluting medical devices
Application:
11/216,312 →
Publication:
US 2007/0048350
Pharmaceutical dosage forms of stable amorphous rapamycin like compounds
Application:
11/237,301 →
Publication:
US 2006/0094744
Local Administration of a Combination of Rapamycin and Cilostazol for the Treatment of Vascular Disease
Local vascular delivery of PI3 kinase inhibitors alone or in combination with sirolimus to prevent restinosis following vascular injury
Application:
11/285,866 →
Publication:
US 2007/0116736
Absorbable stent comprising coating for controlling degradation and maintaining pH neutrality
Application:
11/297,944 →
Publication:
US 2007/0135908
Isomers of rapamycin and 42-Epi-rapamycin, methods of making and using the same
Application:
11/364,305 →
Publication:
US 2007/0203168
Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same
Application:
11/364,313 →
Publication:
US 2007/0203169
Epimers and isomers of tetrazole containing rapamycin analogs, methods of making and using the same
Application:
11/364,381 →
Publication:
US 2007/0225313
Rapamycin Analogs Containing an Antioxidant Moiety
Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same
Application:
11/364,447 →
Publication:
US 2007/0203171
Isomers and 42-Epimers of Rapamycin Alkyl Ether Analogs, Methods of Making and Using the Same
Medical devices, drug coatings and methods of maintaining the drug coatings thereon
Application:
11/437,572 →
Publication:
US 2006/0222756
Local drug delivery devices and methods for maintaining the drug coatings thereon
Application:
11/454,407 →
Publication:
US 2006/0235503
Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease
Application:
11/467,099 →
Publication:
US 2007/0026036
Intraluminal Devices for the Prevention and Treatment of Vascular Disease
Application:
11/566,707 →
Publication:
US 2007/0087028
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 30, 2000
From: KOPIA, GREGORY A.; LLANOS, GERALD H.; FALOTICO, ROBERT
To: CORDIS CORPORATION
Reel/Frame 011207/0681 →
Assignment of Assignor's Interest
Jan 11, 2002
From: LLANOS, GERARD H.; NARAYANAN, PALLASSANA; ROLLER, MARK B.; SCOPELIANOS, ANGELO
To: ETHICON, INC.
Reel/Frame 012486/0244 →
Assignment of Assignor's Interest
Jan 18, 2002
From: DAVILA, LUIS A.; LENTZ, DAVID CHRISTIAN; LLANOS, GERARD H.; MENDEZ, JORGE ORLANDO
To: CORDIS CORPORATION
Reel/Frame 012537/0881 →
Assignment of Assignor's Interest
Feb 19, 2002
From: LENTZ, DAVID CHRISTIAN; LLANOS, GERARD H.; ROLLER, MARK B.; SCOPELIANOS, ANGELO GEORGE
To: CORDIS CORPORATION
Reel/Frame 012635/0912 →
Assignment of Assignor's Interest
May 30, 2002
From: KHAN, I. JOHN; BURGERMEISTER, ROBERT; FISCHELL, ROBERT E.; FISCHELL, DAVID R.
To: CORDIS CORPORATION
Reel/Frame 012956/0964 →
Assignment of Assignor's Interest
Sep 9, 2002
From: FISCHELL, DAVID R.; SPALTRO, JOHN J.
To: CORDIS CORPORATION
Reel/Frame 013065/0803 →
Assignment of Assignor's Interest
Oct 21, 2002
From: EVENS, CARL J.; WEADOCK, KEVIN
To: CORDIS CORPORATION
Reel/Frame 013450/0434 →
Assignment of Assignor's Interest
Oct 21, 2002
From: WEADOCK, KEVIN
To: CORDIS CORPORATION
Reel/Frame 013413/0523 →
Assignment of Assignor's Interest
Nov 8, 2002
From: BOSMA, GJALT; VAN DER MEULEN, DE HEER JOOST
To: CORDIS CORPORATION
Reel/Frame 013471/0385 →
Assignment of Assignor's Interest
Dec 4, 2002
From: LLANOS, GERARD H.; LENTZ, CHRISTIAN
To: CORDIS CORPORATION
Reel/Frame 013536/0350 →
Assignment of Assignor's Interest
Jul 21, 2003
From: LLANOS, GERARD H.
To: CORDIS CORPORATION
Reel/Frame 014302/0352 →
Assignment of Assignor's Interest
Jul 21, 2003
From: CARTER, ANDREW J.
To: CORDIS CORPORATION
Reel/Frame 014297/0348 →
Assignment of Assignor's Interest
Jul 21, 2003
From: KOPIA, GREGORY A.
To: CORDIS CORPORATION
Reel/Frame 014297/0355 →
Assignment of Assignor's Interest
Jul 21, 2003
From: LLANOS, GERARD H.
To: CORDIS CORPORATION
Reel/Frame 014297/0367 →
Assignment of Assignor's Interest
Jul 21, 2003
From: KOPIA, GREGORY A.
To: CORDIS CORPORATION
Reel/Frame 014302/0235 →
Assignment of Assignor's Interest
Jul 21, 2003
From: CARTER, ANDREW J.
To: CORDIS CORPORATION
Reel/Frame 014302/0349 →
Assignment of Assignor's Interest
Jan 23, 2007
From: FALOTICO, ROBERT; SPALTRO, JOHN
To: CORDIS CORPORATION
Reel/Frame 018802/0322 →
Assignment of Assignor's Interest
Dec 5, 2007
From: ETHICON, INC.
To: CORDIS CORPORATION
Reel/Frame 020201/0026 →
Assignment of Assignor's Interest
Sep 17, 2009
From: FALOTICO, ROBERT
To: CORDIS CORPORATION; WYETH
Reel/Frame 023247/0158 →
Assignment of Assignor's Interest
Oct 13, 2015
From: CORDIS CORPORATION
To: ETHICON, INC.
Reel/Frame 036781/0657 →
Assignment of Assignor's Interest
Mar 31, 2017
From: CORDIS CORPORATION
To: CARDINAL HEALTH SWITZERLAND 515 GMBH
Reel/Frame 042126/0259 →